These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 36429003

  • 1. Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells.
    Yang Y, Li D, Wan F, Chen B, Wu G, Li F, Ren Y, Liang P, Wan J, Songyang Z.
    Cells; 2022 Nov 11; 11(22):. PubMed ID: 36429003
    [Abstract] [Full Text] [Related]

  • 2. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A, Ishida T, Yoshimura M, Kimura Y, Sawa S.
    Plant Cell Physiol; 2019 Oct 01; 60(10):2255-2262. PubMed ID: 31198958
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Position-dependent sequence motif preferences of SpCas9 are largely determined by scaffold-complementary spacer motifs.
    Huszár K, Welker Z, Györgypál Z, Tóth E, Ligeti Z, Kulcsár PI, Dancsó J, Tálas A, Krausz SL, Varga É, Welker E.
    Nucleic Acids Res; 2023 Jun 23; 51(11):5847-5863. PubMed ID: 37140059
    [Abstract] [Full Text] [Related]

  • 6. [The Development of SpCas9 Variants with High Specificity and Efficiency Based on the HH Theory].
    Wang GH, Wang CM, Wu XJ, Chu T, Huang DW, Li J.
    Mol Biol (Mosk); 2024 Jun 23; 58(1):157-159. PubMed ID: 38943587
    [Abstract] [Full Text] [Related]

  • 7. A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9.
    Maji B, Gangopadhyay SA, Lee M, Shi M, Wu P, Heler R, Mok B, Lim D, Siriwardena SU, Paul B, Dančík V, Vetere A, Mesleh MF, Marraffini LA, Liu DR, Clemons PA, Wagner BK, Choudhary A.
    Cell; 2019 May 02; 177(4):1067-1079.e19. PubMed ID: 31051099
    [Abstract] [Full Text] [Related]

  • 8. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M, Concordet JP.
    J Genet Genomics; 2016 May 20; 43(5):239-50. PubMed ID: 27210042
    [Abstract] [Full Text] [Related]

  • 9. A highly specific SpCas9 variant is identified by in vivo screening in yeast.
    Casini A, Olivieri M, Petris G, Montagna C, Reginato G, Maule G, Lorenzin F, Prandi D, Romanel A, Demichelis F, Inga A, Cereseto A.
    Nat Biotechnol; 2018 Mar 20; 36(3):265-271. PubMed ID: 29431739
    [Abstract] [Full Text] [Related]

  • 10. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
    Li F, Hung SSC, Mohd Khalid MKN, Wang JH, Chrysostomou V, Wong VHY, Singh V, Wing K, Tu L, Bender JA, Pébay A, King AE, Cook AL, Wong RCB, Bui BV, Hewitt AW, Liu GS.
    Hum Gene Ther; 2019 Nov 20; 30(11):1349-1360. PubMed ID: 31373227
    [Abstract] [Full Text] [Related]

  • 11. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W, Zhang H, Zhang Y, Wang Y, Gan J, Ji Q.
    PLoS Biol; 2019 Oct 20; 17(10):e3000496. PubMed ID: 31603896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Structural insights into a high fidelity variant of SpCas9.
    Guo M, Ren K, Zhu Y, Tang Z, Wang Y, Zhang B, Huang Z.
    Cell Res; 2019 Mar 20; 29(3):183-192. PubMed ID: 30664728
    [Abstract] [Full Text] [Related]

  • 14. Electronic Circular Dichroism of the Cas9 Protein and gRNA:Cas9 Ribonucleoprotein Complex.
    Halat M, Klimek-Chodacka M, Orleanska J, Baranska M, Baranski R.
    Int J Mol Sci; 2021 Mar 13; 22(6):. PubMed ID: 33805827
    [Abstract] [Full Text] [Related]

  • 15. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
    Evmenov K, Pustogarov N, Panteleev D, Safin A, Alkalaeva E.
    Int J Mol Sci; 2024 Jan 28; 25(3):. PubMed ID: 38338898
    [Abstract] [Full Text] [Related]

  • 16. In Planta Processing of the SpCas9-gRNA Complex.
    Mikami M, Toki S, Endo M.
    Plant Cell Physiol; 2017 Nov 01; 58(11):1857-1867. PubMed ID: 29040704
    [Abstract] [Full Text] [Related]

  • 17. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
    Barkau CL, O'Reilly D, Rohilla KJ, Damha MJ, Gagnon KT.
    Nucleic Acid Ther; 2019 Jun 01; 29(3):136-147. PubMed ID: 30990769
    [Abstract] [Full Text] [Related]

  • 18. Engineered dual selection for directed evolution of SpCas9 PAM specificity.
    Goldberg GW, Spencer JM, Giganti DO, Camellato BR, Agmon N, Ichikawa DM, Boeke JD, Noyes MB.
    Nat Commun; 2021 Jan 13; 12(1):349. PubMed ID: 33441553
    [Abstract] [Full Text] [Related]

  • 19. Combinatorial mutagenesis en masse optimizes the genome editing activities of SpCas9.
    Choi GCG, Zhou P, Yuen CTL, Chan BKC, Xu F, Bao S, Chu HY, Thean D, Tan K, Wong KH, Zheng Z, Wong ASL.
    Nat Methods; 2019 Aug 13; 16(8):722-730. PubMed ID: 31308554
    [Abstract] [Full Text] [Related]

  • 20. Allosteric inhibition of CRISPR-Cas9 by bacteriophage-derived peptides.
    Cui YR, Wang SJ, Chen J, Li J, Chen W, Wang S, Meng B, Zhu W, Zhang Z, Yang B, Jiang B, Yang G, Ma P, Liu J.
    Genome Biol; 2020 Feb 26; 21(1):51. PubMed ID: 32102684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.